STAMFORD, Conn., June 05, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with ...
The FDA has extended the PDUFA goal date for Eton's ET-400 NDA to May 28, 2025, indicating the FDA's commitment to thoroughly reviewing the application, which Eton believes addresses all requested ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results